2022
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy
Patel K, Lansky A, Kereiakes D, Windecker S, Cristea E, Pietras C, Dressler O, Issever M, Curtis M, Bertolet B, Zidar J, Smits P, DĂaz V, McLaurin B, Brogno D, Janssens L, Vrolix M, GĂłmez-Blázquez I, Sahul Z, Kabour A, Salido L, Cleman M, Saito S, Leon M, Baumbach A, Investigators I. Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100004. PMID: 39130138, PMCID: PMC11308031, DOI: 10.1016/j.jscai.2021.100004.Peer-Reviewed Original ResearchDrug-eluting stentsTarget lesion failureDP-EESComplex lesionsLesion failureAdverse eventsLesion complexityMajor adverse cardiac eventsSingle-blind clinical trialEnd pointAdverse cardiac eventsChronic coronary syndromePrimary end pointSecondary end pointsTarget lesion revascularizationTarget vessel failureComplex coronary lesionsPercutaneous coronary interventionEverolimus-eluting stentsDrug eluting stentsHigh rateLesion revascularizationCoronary syndromeCardiac eventsCoronary intervention
2014
TCT-786 In-Hospital Outcomes of balloon aortic valvuloplasty and percutaneous coronary intervention during the same hospitalization in the US
Singh V, Patel N, Badheka A, Patel N, Macon C, Savani G, Patel J, Thakkar B, Manvar S, Panchal V, Solanki S, Patel N, Chothani A, Kliger C, Schreiber T, O'Neill W, Cohen M, Alfonso C, Grines C, Forrest J, Cleman M, Makkar R. TCT-786 In-Hospital Outcomes of balloon aortic valvuloplasty and percutaneous coronary intervention during the same hospitalization in the US. Journal Of The American College Of Cardiology 2014, 64: b230. DOI: 10.1016/j.jacc.2014.07.859.Peer-Reviewed Original ResearchIn-Hospital OutcomesPercutaneous coronary interventionCoronary interventionSame hospitalizationHospitalization
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply